Advertisement

PharmacoEconomics & Outcomes News

, Volume 820, Issue 1, pp 14–14 | Cite as

Enzyme screening less costly than genetic testing for Fabry's disease

Clinical study
  • 4 Downloads

Reference

  1. Newman DB, et al. Cost Efficacy of alpha-Galactosidase A Enzyme Screening for Fabry Disease. Mayo Clinic Proceedings 94: 84-88, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1016/j.mayocp.2018.08.009 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations